Summary & Overview
CPT 93150: Activation and Programming of Implanted Phrenic Nerve Stimulator
CPT code 93150 covers the activation, evaluation, and programming of an implanted phrenic nerve stimulation system used to provide diaphragmatic pacing for patients with respiratory insufficiency. This code documents the specialized, device-focused service performed after implantation to set and optimize stimulation parameters. Nationally, the code is important as adoption of implantable respiratory neuromodulation grows and payers clarify coverage and payment for advanced device management.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes payer coverage patterns, typical reimbursement considerations, and clinical context for use of the code. It highlights what clinicians and billing teams need to know about where the service is usually performed and how it is documented.
Readers will learn: an overview of clinical indications and the procedural nature of the service; expected sites of care for activation and programming; common billing and documentation touchpoints; and where to find relevant policy statements or coverage determinations. Data not available in the input is noted when specific payer policy details, ICD-10 pairings, and related codes are not provided.
Billing Code Overview
CPT code 93150 describes therapy activation of an implanted phrenic nerve stimulation system, including evaluation and programming of the device. The service involves initiating and adjusting stimulation parameters after implantation to achieve effective diaphragmatic pacing for patients with conditions that impair respiratory function.
Service type: Device programming and evaluation / Therapeutic device activation
Typical site of service: Hospital inpatient or outpatient setting, outpatient clinic, or specialized device clinic where implanted neuromodulation systems are managed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with chronic central hypoventilation or persistent diaphragmatic weakness causing hypoventilatory respiratory failure who previously underwent implantation of a phrenic nerve stimulation system. The patient presents to an outpatient device clinic or ambulatory surgical center for initial activation and programming of the implanted stimulator after lead maturation and wound healing (commonly 2–6 weeks post-implant). The clinical workflow includes a focused history and review of systems for respiratory symptoms, assessment of wound and lead status, baseline pulmonary status evaluation (oxygen saturation, respiratory rate, possibly capnography), interrogation of the implanted neurostimulation system with manufacturer programmer to confirm lead integrity and device telemetry, titration of stimulation amplitude, pulse width, and frequency to achieve adequate diaphragmatic contraction while monitoring for adverse effects (pain, arrhythmia, cough, syncope), documentation of settings and patient response, patient/caregiver education on device use and troubleshooting, and scheduling follow-up visits for further optimization. Typical sites of service are outpatient hospital-based device clinic, ambulatory surgical center, or physician office with appropriate programming equipment and monitoring support.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Standard procedural modifier indicating no modifier applies | Rarely reported; use only if billing system requires a default modifier when no other modifier is appropriate |